Concepedia

Publication | Open Access

Esketamine Nasal Spray Plus Oral Antidepressant in Patients With Treatment-Resistant Depression

261

Citations

3

References

2020

Year

Abstract

ClinicalTrials.gov identifier: NCT02497287.

References

YearCitations

Page 1